Viracta Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
VANGUARD GROUP INC | 02/11/2025 | 289,174 | $46,557 | -69.70% | 0.73% |
AISLING CAPITAL MANAGEMENT LP | 02/12/2025 | 288,571 | $46,171 | 0.00% | 0.73% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 286,395 | $46,081 | 16.71% | 0.72% |
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 234,846 | $37,787 | 0.00% | 0.59% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 224,250 | $36,095 | -10.30% | 0.57% |
VIRTU FINANCIAL LLC | 02/11/2025 | 128,231 | $21,000 | 100.00% | 0.32% |
UBS GROUP AG | 02/14/2025 | 93,177 | $15,001 | 97,981.05% | 0.24% |
HRT FINANCIAL LP | 02/14/2025 | 82,673 | $13,000 | -40.45% | 0.21% |
JANE STREET GROUP, LLC | 02/14/2025 | 55,422 | $8,917 | 100.00% | 0.14% |
UNITED CAPITAL FINANCIAL ADVISERS, LLC | 02/13/2025 | 42,995 | $6,879 | 0.00% | 0.11% |
INSPIRION WEALTH ADVISORS, LLC | 01/15/2025 | 25,000 | $5,275 | 0.00% | 0.06% |
TWO SIGMA SECURITIES, LLC | 02/14/2025 | 16,491 | $2,653 | 100.00% | 0.04% |
WEALTHTRUST AXIOM LLC | 02/13/2025 | 16,396 | $2,638 | 0.00% | 0.04% |
XTX TOPCO LTD | 02/13/2025 | 14,809 | $2,383 | 45.56% | 0.04% |
TRUST CO OF TOLEDO NA /OH/ | 01/13/2025 | 12,317 | $1,982 | 0.00% | 0.03% |
BAADER BANK AKTIENGESELLSCHAFT | 01/23/2025 | 10,826 | $1,559 | 100.00% | 0.03% |
MAI CAPITAL MANAGEMENT | 02/14/2025 | 4,018 | $647 | 100.00% | 0.01% |
RP MANAGEMENT, LLC | 02/03/2025 | 3,700 | $851 | 0.00% | 0.01% |
IAG WEALTH PARTNERS, LLC | 02/10/2025 | 3,000 | $483 | 0.00% | 0.01% |
OARSMAN CAPITAL, INC. | 02/13/2025 | 1,000 | $161 | 0.00% | 0.00% |
JPMORGAN CHASE & CO | 02/12/2025 | 721 | $116 | 0.00% | 0.00% |
INDIANA TRUST & INVESTMENT MANAGEMENT CO | 01/29/2025 | 200 | $32 | 0.00% | 0.00% |
02/06/2025 | 180 | $29 | 100.00% | 0.00% | |
WELLS FARGO & COMPANY/MN | 02/13/2025 | 171 | $28 | 0.00% | 0.00% |
PARALLEL ADVISORS, LLC | 02/10/2025 | 8 | $1 | 0.00% | 0.00% |
ADDISON ADVISORS LLC | 02/04/2025 | 4 | $1 | 0.00% | 0.00% |
JONES FINANCIAL COMPANIES LLLP | 02/06/2025 | 0 | $0 | -100.00% | 0.00% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
ROYAL BANK OF CANADA | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
LAURION CAPITAL MANAGEMENT LP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
STONEPINE CAPITAL MANAGEMENT, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 02/12/2025 | 0 | $0 | -100.00% | 0.00% |
COLONY GROUP, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
SAMSARA BIOCAPITAL, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
DUNHILL FINANCIAL, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
Viracta Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 48 institutional investors and hedge funds held shares of Viracta Therapeutics, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 289,174
Aisling Capital Management LP: 288,571
RENAISSANCE TECHNOLOGIES LLC: 286,395
BlackRock Funding, Inc. /DE: 234,846
GEODE CAPITAL MANAGEMENT, LLC: 224,250
Virtu Financial LLC: 128,231
9.10% of Viracta Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 3.81 M shares in the last 24 months. This purchase volume represents approximately $799,262 in transactions.